Italy Patient Monitoring Market by Product (Cardiac Monitoring Devices, Blood Glucose Monitoring Systems, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Weight Monitoring Devices, and Other Devices), by Type (Conventional and Wireless), and by End User (Home Healthcare, Hospitals & Clinics, and Others) - Opportunity Analysis and Industry Forecast, 2024–2030

Italy Patient Monitoring Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  148 | No. Tables:  110 | No. Figures:  75

Market Definition

The Italy Patient Monitoring Market size was valued at USD 1.46 billion in 2023, and is predicted to reach USD 2.40 billion by 2030, with a CAGR of 7.1% from 2024 to 2030. Patient monitoring is a crucial component of modern healthcare, involving the ongoing or periodic evaluation of a patient's vital signs, physiological measurements, and general health status throughout their medical care. This process utilizes a variety of medical devices and technologies to gather, record, and analyze data such as blood pressure, heart rate, oxygen saturation, respiratory rate, temperature, and other essential indicators.

The patient monitoring market encompasses the healthcare industry segment responsible for developing, manufacturing, and supplying equipment and systems for the continuous or intermittent monitoring and recording of a patient's vital signs and health parameters. This segment plays a pivotal role in a wide array of healthcare settings, including hospitals and intensive care units, outpatient clinics, and home healthcare. This ensures that patients receive the appropriate level of care tailored to their specific medical needs.

Rising Aging Population Creates Demand for Patient Monitoring Systems

Italy is experiencing a demographic shift characterized by an increasing proportion of elderly individuals in its population. As people age, there is often a higher prevalence of chronic illnesses and health conditions that require ongoing medical attention. This demographic trend places a greater demand on healthcare systems to provide effective monitoring and management of various health parameters. Patient monitoring systems play a vital role in this context by allowing healthcare providers to keep track of the health status of elderly patients, especially those with chronic diseases.

 

Rising Chronic Diseases Drives the Patient Monitoring Market

The escalating prevalence of chronic diseases, encompassing cardiovascular disorders, diabetes, and respiratory ailments, is further propelling the growth of the patient monitoring market in Italy. Patient monitoring devices play a crucial role in managing chronic conditions by providing real-time data on vital signs and medication adherence, enabling timely interventions and preventive measures. This growing burden of chronic diseases necessitates advanced healthcare solutions, fostering increased investment in patient monitoring technologies.

 

Connectivity Issues in Patient Monitoring Devices Restrain the Market Growth

One of the significant restraining factors in the patient monitoring market in Italy is the connectivity issues which pose a risk to real-time data transmission and communication between devices, impacting the timeliness and accuracy of patient information. Addressing these challenges is crucial for unlocking the full potential of patient monitoring technologies and ensuring their widespread adoption in the healthcare sector.

Advent of AI and Machine Learning in Patient Monitoring Systems Create Future Growth Opportunities

AI and ML are revolutionizing patient monitoring by enabling the in-depth analysis of vast amounts of data. By analyzing historical patient data, AI algorithms can detect subtle patterns and anomalies in vital signs and medical history, allowing for early identification of potential health problems before symptoms appear. This early detection capability facilitates timely interventions that can improve patient outcomes.

Furthermore, AI and ML support personalized medicine by enabling the tailoring of treatment plans to individual patient characteristics and responses. These technologies help in risk stratification, assisting healthcare providers in prioritizing interventions for patients at higher risk of developing specific medical conditions or complications.

 

Competitive Landscape

Various market players operating in the Italy patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Nihon Kohden Corporation, Abbott Laboratories, Masimo Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Honeywell International, Inc., and others.

Italy Patient Monitoring Key Market Segments

By Product

  • Cardiac Monitoring Devices

    • Mobile Cardiac Telemetry Monitors

    • Electrocardiogram (ECG) Devices

    • Implantable Loop Recorders

    • Event Monitors

    • Smart/Wearable ECG Monitors

  • Blood Glucose Monitoring Systems

    • Self-Monitoring Blood Glucose Systems

    • Continuous Glucose Monitoring Systems

  • Hemodynamic/Pressure Monitoring Devices

    • Hemodynamic Monitors

    • Blood Pressure Monitors

    • Disposables 

  • Multi-Parameter Monitoring Devices

    • Low-Acuity Monitoring Device

    • Mid-Acuity Monitoring Devices

    • High-Acuity Monitoring Devices

  • Respiratory Monitoring Devices

    • Pulse Oximeters

    • Spirometers

    • Capnographs

    • Peak Flow Meters

  • Temperature Monitoring Device

    • Handheld Temperature Monitoring Devices

    • Table-Top Temperature Monitoring Devices

    • Wearable Continuous Monitoring Devices

    • Invasive Temperature Monitoring Devices

    • Smart Temperature Monitoring Devices

  • Fetal & Neonatal Monitoring Devices

    • Neonatal Monitoring Devices

    • Fetal Monitoring Devices

  • Neuromonitoring Devices

    • Electroencephalograph (EEG) Machines

    • Electromyography Machines

    • Cerebral Oximeter

    • Intracranial Pressure (ICP) Monitors

    • Magnetoencephalography (MEG) Machines

    • Transcranial Doppler (TCD) Machines

  • Weight Monitoring Devices

    • Digital

    • Analog

  • Others Devices

By Type

  • Conventional

  • Wireless

By End User

  • Home Healthcare

  • Hospitals & Clinics

  • Others

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 1.46 Billion

Revenue Forecast in 2030

USD 2.40 Billion

Revenue Growth Rate

CAGR of 7.1 % from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

Rising aging population creates demand for patient monitoring systems

Increasing chronic diseases drives the patient monitoring market

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      ITALY PATIENT MONITORING MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6       ITALY PATIENT MONITORING MARKET BY PRODUCT

           6.1      OVERVIEW

           6.2      CARDIAC MONITORING DEVICES MARKET

                         6.2.1      MOBILE CARDIAC TELEMETRY MONITORS

                         6.2.2      ELECTROCARDIOGRAM (ECG) DEVICES

                         6.2.3      IMPLANTABLE LOOP RECORDERS

                         6.2.4      EVENT MONITORS

                         6.2.5      SMART/WEARABLE ECG MONITORS

           6.3      BLOOD GLUCOSE MONITORING SYSTEMS MARKET

                         6.3.1      SELF-MONITORING BLOOD GLUCOSE SYSTEMS

                         6.3.2      CONTINUOUS GLUCOSE MONITORING SYSTEMS

           6.4      HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET

                         6.4.1      HEMODYNAMIC MONITORS

                         6.4.2      BLOOD PRESSURE MONITORS

                         6.4.3      DISPOSABLES

           6.5      MULTI-PARAMETER MONITORING DEVICES MARKET

                         6.5.1      LOW-ACUITY MONITORING DEVICE

                         6.5.2      MID-ACUITY MONITORING DEVICES

                         6.5.3      HIGH-ACUITY MONITORING DEVICES

           6.6      RESPIRATORY MONITORING DEVICES MARKET

                         6.6.1      PULSE OXIMETERS

                         6.6.2      SPIROMETERS

                         6.6.3      CAPNOGRAPHS

                         6.6.4      PEAK FLOW METERS

           6.7      TEMPERATURE MONITORING DEVICE MARKET

                         6.7.1      HANDHELD TEMPERATURE MONITORING DEVICES

                         6.7.2      TABLE-TOP TEMPERATURE MONITORING DEVICES

                         6.7.3      WEARABLE CONTINUOUS MONITORING DEVICES

                         6.7.4      INVASIVE TEMPERATURE MONITORING DEVICES

                         6.7.5      SMART TEMPERATURE MONITORING DEVICES

           6.8      FETAL AND NEONATAL MONITORING DEVICES MARKET

                         6.8.1      NEONATAL MONITORING DEVICES

                         6.8.2      FETAL MONITORING DEVICES

           6.9      NEUROMONITORING DEVICES MARKET

                         6.9.1      ELECTROENCEPHALOGRAPH (EEG) MACHINES

                         6.9.2      ELECTROMYOGRAPHY MACHINES

                         6.9.3      CEREBRAL OXIMETER

                         6.9.4      INTRACRANIAL PRESSURE (ICP) MONITORS

                         6.9.5      MAGNETOENCEPHALOGRAPHY (MEG) MACHINES

                         6.9.6      TRANSCRANIAL DOPPLER (TCD) MACHINES

           6.10      WEIGHT MONITORING DEVICES MARKET

                         6.10.1      DIGITAL

                         6.10.2      ANALOG

           6.11      OTHERS DEVICES MARKET

7       ITALY PATIENT MONITORING MARKET BY TYPE

           7.1      OVERVIEW

           7.2      CONVENTIONAL MARKET

           7.3      WIRELESS MARKET

8       ITALY PATIENT MONITORING MARKET BY END USER

           8.1      OVERVIEW

           8.2      HOME HEALTHCARE MARKET

           8.3      HOSPITALS AND CLINICS MARKET

           8.4      OTHERS MARKET

9     COMPANY PROFILES

           9.1     MEDTRONIC PLC

                         9.1.1     COMPANY OVERVIEW

                         9.1.2     COMPANY SNAPSHOT

                         9.1.3     OPERATING BUSINESS SEGMENTS

                         9.1.4     PRODUCT PORTFOLIO

                         9.1.5     BUSINESS PERFORMANCE

                         9.1.6     BUSINESS SEGMENTS

                         9.1.7     GEOGRAPHIC SEGMENTS

                         9.1.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.1.9     PRIMARY MARKET COMPETITORS

           9.2     KONINKLIJKE PHILIPS N.V.

                         9.2.1     COMPANY OVERVIEW

                         9.2.2     COMPANY SNAPSHOT

                         9.2.3     OPERATING BUSINESS SEGMENTS

                         9.2.4     PRODUCT PORTFOLIO

                         9.2.5     BUSINESS PERFORMANCE

                         9.2.6     BUSINESS SEGMENTS

                         9.2.7     GEOGRAPHIC SEGMENTS

                         9.2.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.2.9     PRIMARY MARKET COMPETITORS

           9.3     GE HEALTHCARE

                         9.3.1     COMPANY OVERVIEW

                         9.3.2     COMPANY SNAPSHOT

                         9.3.3     OPERATING BUSINESS SEGMENTS

                         9.3.4     PRODUCT PORTFOLIO

                         9.3.5     BUSINESS PERFORMANCE

                         9.3.6     BUSINESS SEGMENTS

                         9.3.7     GEOGRAPHIC SEGMENTS

                         9.3.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.3.9     PRIMARY MARKET COMPETITORS

           9.4     SIEMENS HEALTHINEERS

                         9.4.1     COMPANY OVERVIEW

                         9.4.2     COMPANY SNAPSHOT

                         9.4.3     OPERATING BUSINESS SEGMENTS

                         9.4.4     PRODUCT PORTFOLIO

                         9.4.5     BUSINESS PERFORMANCE

                         9.4.6     BUSINESS SEGMENTS

                         9.4.7     GEOGRAPHIC SEGMENTS

                         9.4.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.4.9     PRIMARY MARKET COMPETITORS

           9.5     NIHON KOHDEN CORPORATION

                         9.5.1     COMPANY OVERVIEW

                         9.5.2     COMPANY SNAPSHOT

                         9.5.3     OPERATING BUSINESS SEGMENTS

                         9.5.4     PRODUCT PORTFOLIO

                         9.5.5     BUSINESS PERFORMANCE

                         9.5.6     BUSINESS SEGMENTS

                         9.5.7     GEOGRAPHIC SEGMENTS

                         9.5.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.5.9     PRIMARY MARKET COMPETITORS

           9.6     ABBOTT LABORATORIES

                         9.6.1     COMPANY OVERVIEW

                         9.6.2     COMPANY SNAPSHOT

                         9.6.3     OPERATING BUSINESS SEGMENTS

                         9.6.4     PRODUCT PORTFOLIO

                         9.6.5     BUSINESS PERFORMANCE

                         9.6.6     BUSINESS SEGMENTS

                         9.6.7     GEOGRAPHIC SEGMENTS

                         9.6.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.6.9     PRIMARY MARKET COMPETITORS

           9.7     MASIMO CORPORATION

                         9.7.1     COMPANY OVERVIEW

                         9.7.2     COMPANY SNAPSHOT

                         9.7.3     OPERATING BUSINESS SEGMENTS

                         9.7.4     PRODUCT PORTFOLIO

                         9.7.5     BUSINESS PERFORMANCE

                         9.7.6     BUSINESS SEGMENTS

                         9.7.7     GEOGRAPHIC SEGMENTS

                         9.7.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.7.9     PRIMARY MARKET COMPETITORS

           9.8     HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG

                         9.8.1     COMPANY OVERVIEW

                         9.8.2     COMPANY SNAPSHOT

                         9.8.3     OPERATING BUSINESS SEGMENTS

                         9.8.4     PRODUCT PORTFOLIO

                         9.8.5     BUSINESS PERFORMANCE

                         9.8.6     BUSINESS SEGMENTS

                         9.8.7     GEOGRAPHIC SEGMENTS

                         9.8.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.8.9     PRIMARY MARKET COMPETITORS

           9.9     BIOTRONIK SE AND CO. KG

                         9.9.1     COMPANY OVERVIEW

                         9.9.2     COMPANY SNAPSHOT

                         9.9.3     OPERATING BUSINESS SEGMENTS

                         9.9.4     PRODUCT PORTFOLIO

                         9.9.5     BUSINESS PERFORMANCE

                         9.9.6     BUSINESS SEGMENTS

                         9.9.7     GEOGRAPHIC SEGMENTS

                         9.9.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.9.9     PRIMARY MARKET COMPETITORS

           9.10     HONEYWELL INTERNATIONAL, INC.

                         9.10.1     COMPANY OVERVIEW

                         9.10.2     COMPANY SNAPSHOT

                         9.10.3     OPERATING BUSINESS SEGMENTS

                         9.10.4     PRODUCT PORTFOLIO

                         9.10.5     BUSINESS PERFORMANCE

                         9.10.6     BUSINESS SEGMENTS

                         9.10.7     GEOGRAPHIC SEGMENTS

                         9.10.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.10.9     PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. ITALY PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

TABLE 2. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 5. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 11. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 13. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 14. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 15. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 16. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 17. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 18. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 19. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 20. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 21. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 22. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 23. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 24. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 25. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 26. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 27. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 28. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 29. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 30. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 31. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 32. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 33. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 34. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 35. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 36. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 37. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 38. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 39. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 40. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 41. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 42. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 43. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 44. ITALY PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

TABLE 45. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 46. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 47. ITALY PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 48. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 49. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 50. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 51. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 52. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS

TABLE 53. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 54. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 55. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 56. MEDTRONIC PLC: KEY STRATERGY

TABLE 57. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 58. KONINKLIJKE PHILIPS N.V.: OPERATING BUSINESS SEGMENTS

TABLE 59. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 60. KONINKLIJKE PHILIPS N.V.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 61. KONINKLIJKE PHILIPS N.V.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 62. KONINKLIJKE PHILIPS N.V.: KEY STRATERGY

TABLE 63. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 64. GE HEALTHCARE: OPERATING BUSINESS SEGMENTS

TABLE 65. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 66. GE HEALTHCARE: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 67. GE HEALTHCARE: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 68. GE HEALTHCARE: KEY STRATERGY

TABLE 69. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

TABLE 70. SIEMENS HEALTHINEERS: OPERATING BUSINESS SEGMENTS

TABLE 71. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO

TABLE 72. SIEMENS HEALTHINEERS: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 73. SIEMENS HEALTHINEERS: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 74. SIEMENS HEALTHINEERS: KEY STRATERGY

TABLE 75. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 76. NIHON KOHDEN CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 77. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 78. NIHON KOHDEN CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 79. NIHON KOHDEN CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 80. NIHON KOHDEN CORPORATION: KEY STRATERGY

TABLE 81. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 82. ABBOTT LABORATORIES: OPERATING BUSINESS SEGMENTS

TABLE 83. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 84. ABBOTT LABORATORIES: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 85. ABBOTT LABORATORIES: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 86. ABBOTT LABORATORIES: KEY STRATERGY

TABLE 87. MASIMO CORPORATION: COMPANY SNAPSHOT

TABLE 88. MASIMO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 89. MASIMO CORPORATION: PRODUCT PORTFOLIO

TABLE 90. MASIMO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 91. MASIMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 92. MASIMO CORPORATION: KEY STRATERGY

TABLE 93. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 94. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 95. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 96. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 97. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 98. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 99. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT

TABLE 100. BIOTRONIK SE AND CO. KG: OPERATING BUSINESS SEGMENTS

TABLE 101. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO

TABLE 102. BIOTRONIK SE AND CO. KG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 103. BIOTRONIK SE AND CO. KG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 104. BIOTRONIK SE AND CO. KG: KEY STRATERGY

TABLE 105. HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 106. HONEYWELL INTERNATIONAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 107. HONEYWELL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 108. HONEYWELL INTERNATIONAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 109. HONEYWELL INTERNATIONAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 110. HONEYWELL INTERNATIONAL, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. ITALY PATIENT MONITORING MARKET VALUE, BY PRODUCT, 2023-2030, (MILLION USD)

FIGURE 7. CARDIAC MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. MOBILE CARDIAC TELEMETRY MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. ELECTROCARDIOGRAM (ECG) DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 10. IMPLANTABLE LOOP RECORDERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. EVENT MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. SMART/WEARABLE ECG MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. BLOOD GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. SELF-MONITORING BLOOD GLUCOSE SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 15. CONTINUOUS GLUCOSE MONITORING SYSTEMS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 16. HEMODYNAMIC/PRESSURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. HEMODYNAMIC MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 18. BLOOD PRESSURE MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 19. DISPOSABLES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 20. MULTI-PARAMETER MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 21. LOW-ACUITY MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 22. MID-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 23. HIGH-ACUITY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 24. RESPIRATORY MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 25. PULSE OXIMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 26. SPIROMETERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 27. CAPNOGRAPHS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 28. PEAK FLOW METERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 29. TEMPERATURE MONITORING DEVICE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 30. HANDHELD TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 31. TABLE-TOP TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 32. WEARABLE CONTINUOUS MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 33. INVASIVE TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 34. SMART TEMPERATURE MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 35. FETAL AND NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 36. NEONATAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 37. FETAL MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 38. NEUROMONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 39. ELECTROENCEPHALOGRAPH (EEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 40. ELECTROMYOGRAPHY MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 41. CEREBRAL OXIMETER, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 42. INTRACRANIAL PRESSURE (ICP) MONITORS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 43. MAGNETOENCEPHALOGRAPHY (MEG) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 44. TRANSCRANIAL DOPPLER (TCD) MACHINES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 45. WEIGHT MONITORING DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 46. DIGITAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 47. ANALOG, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 48. OTHERS DEVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 49. ITALY PATIENT MONITORING MARKET VALUE, BY TYPE, 2023-2030, (MILLION USD)

FIGURE 50. CONVENTIONAL, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 51. WIRELESS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 52. ITALY PATIENT MONITORING MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 53. HOME HEALTHCARE, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 54. HOSPITALS AND CLINICS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 55. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 56. MEDTRONIC PLC: NET SALES, (2021-2023)

FIGURE 57. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS

FIGURE 58. KONINKLIJKE PHILIPS N.V.: NET SALES, (2021-2023)

FIGURE 59. KONINKLIJKE PHILIPS N.V.: PRIMARY MARKET COMPETITORS

FIGURE 60. GE HEALTHCARE: NET SALES, (2021-2023)

FIGURE 61. GE HEALTHCARE: PRIMARY MARKET COMPETITORS

FIGURE 62. SIEMENS HEALTHINEERS: NET SALES, (2021-2023)

FIGURE 63. SIEMENS HEALTHINEERS: PRIMARY MARKET COMPETITORS

FIGURE 64. NIHON KOHDEN CORPORATION: NET SALES, (2021-2023)

FIGURE 65. NIHON KOHDEN CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 66. ABBOTT LABORATORIES: NET SALES, (2021-2023)

FIGURE 67. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS

FIGURE 68. MASIMO CORPORATION: NET SALES, (2021-2023)

FIGURE 69. MASIMO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 70. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 71. HILL-ROM HOLDINGS, INC.BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 72. BIOTRONIK SE AND CO. KG: NET SALES, (2021-2023)

FIGURE 73. BIOTRONIK SE AND CO. KG: PRIMARY MARKET COMPETITORS

FIGURE 74. HONEYWELL INTERNATIONAL, INC.: NET SALES, (2021-2023)

FIGURE 75. HONEYWELL INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Medtronic Plc

  • Koninklijke Philips N.V.

  • GE Healthcare

  • Siemens Healthineers

  • Nihon Kohden Corporation

  • Abbott Laboratories

  • Masimo Corporation

  • Hill-Rom Holdings, Inc.

  • Biotronik SE & Co. KG

  • Honeywell International, Inc.


Frequently Asked Questions
What is the market size of the Italy patient monitoring market in 2030?

According to Next Move Strategy Consulting, the market size of Italy patient monitoring will be USD 2.40 billion in 2030.

What is the market size of the Italy patient monitoring market in 2023?

According to Next Move Strategy Consulting, the market size of Italy patient monitoring is USD 1.46 billion in 2023.

What role does artificial intelligence (AI) play in patient monitoring?

AI is used to analyze large datasets from patient monitoring devices, helping healthcare providers detect trends and anomalies and predict patient outcomes effectively.

What are the benefits of using wearable patient monitoring devices?

Wearable patient monitoring devices offer real-time data, improved patient comfort, and the ability to track health metrics continuously, which can aid in early disease detection and management.

Which are the top companies operating in the patient monitoring market?

The top companies operating in the patient monitoring market include Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, and Abbott Laboratories.